Reduced Emergency Department Visits and Hospitalizations in Infants after Universal Respiratory Syncytial Virus Immunization, Italy, 2024–25

Emerging infectious diseases 2026 Open access

Read full text
Authors: Simone Villa, Simona Scarioni, E. Pigozzi, Manuel Maffeo, Mauro Maistrello, Giorgio Bagarella, Francesco Scovenna, Federica Morani, Marlen Romano, G Zuccotti, Massimo Agosti, Catia Rosanna Borriello
+8 more Elena Pariani, Guido Bertolaso, Luigi Vezzosi, Fausto Baldanti, Mario Melazzini, Elena Azzolini, Gabriele Del Castillo, Danilo Cereda
DOI: 10.3201/eid3201.250870
Cited by: 7
References: 18

Abstract

During the 2024-25 winter season, a universal immunization campaign with nirsevimab was implemented in a region of Italy to prevent respiratory syncytial virus (RSV) infection among infants

Fields of Study & Subjects

Respiratory viral infections research COVID-19 Clinical Research Studies Virology and Viral Diseases

Publication details

Journal / source
Emerging infectious diseases
Publisher
Centers for Disease Control and Prevention (CDC)
Volume
32
Issue
1
Pages
45–54
Publication date
1 January 2026
Language
EN